Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Ductal, Lobular, and Medullary

Explore clinical trials studying Neoplasms, Ductal, Lobular, and Medullary. Study availability and eligibility vary by location and protocol.

487 public trials 100 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Ductal, Lobular, and Medullary trial results

Recruiting

A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer

NCT05859074

Conditions
Adenocarcinoma, Adenocarcinoma, Sebaceous, Adnexal Carcinoma, +58 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited protocol activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial

NCT06184750

Conditions
Adenocarcinoma, Breast Atypical Ductal Hyperplasia, Breast Atypical Lobular Hyperplasia, +17 more
Locations
  • University of Arizona Cancer Center - Prevention Research Clinic Tucson, Arizona, United States
  • Northwestern University Chicago, Illinois, United States
  • University of Illinois College of Medicine - Chicago Chicago, Illinois, United States
  • University of Kansas Cancer Center Kansas City, Kansas, United States
View Trial Details
Recruiting

DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment

NCT06075953

Conditions
Adenocarcinoma, Breast Carcinoma In Situ, Carcinoma, +7 more
Locations
  • Berkeley Outpatient Center Berkeley, California, United States
  • City of Hope -Duarte Cancer Center Duarte, California, United States
  • City of Hope - Lennar Foundation Cancer Center Irvine, California, United States
  • UCLA Los Angeles, California, United States
View all 28 locations
View Trial Details
Recruiting

Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer

NCT05941520

Conditions
Adenocarcinoma, Breast Atypical Hyperplasia, Breast Carcinoma, +15 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Northwestern University Chicago, Illinois, United States
  • University of Kansas Cancer Center Kansas City, Kansas, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
View Trial Details

Related conditions